<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(7)</volume><submitter>Kalaria AL</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Subclinical rejection (SCR) refers to the presence of acute rejection without accompanying kidney allograft dysfunction. The impact of SCR on long-term graft survival remains a subject of ongoing debate.&lt;h4>Methods and analysis&lt;/h4>We will perform a systematic search of databases including MEDLINE, Embase and Cochrane Central, from January 1995 to November 2023. We will include English-language studies involving adult kidney transplant patients who investigated SCR. We will exclude studies focused on 'for-cause' biopsies. Both title, abstract screening and full-text screening will be performed by two or more reviewers. The primary outcome of this study will be death-censored allograft loss. The secondary outcome will include development of subsequent rejection. For tim</pubmed_abstract><journal>BMJ open</journal><pagination>e085098</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11261677</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Subclinical rejection and allograft survival in kidney transplantation: protocol for a systematic review and meta-analysis.</pubmed_title><pmcid>PMC11261677</pmcid><pubmed_authors>Cruz-Peralta M</pubmed_authors><pubmed_authors>Mehta RB</pubmed_authors><pubmed_authors>Kalaria AL</pubmed_authors><pubmed_authors>Yamada T</pubmed_authors><pubmed_authors>Rahman AZ</pubmed_authors><pubmed_authors>Molinari M</pubmed_authors><pubmed_authors>Klein-Fedyshin M</pubmed_authors><pubmed_authors>Obata S</pubmed_authors><pubmed_authors>Parrish B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Subclinical rejection and allograft survival in kidney transplantation: protocol for a systematic review and meta-analysis.</name><description>&lt;h4>Introduction&lt;/h4>Subclinical rejection (SCR) refers to the presence of acute rejection without accompanying kidney allograft dysfunction. The impact of SCR on long-term graft survival remains a subject of ongoing debate.&lt;h4>Methods and analysis&lt;/h4>We will perform a systematic search of databases including MEDLINE, Embase and Cochrane Central, from January 1995 to November 2023. We will include English-language studies involving adult kidney transplant patients who investigated SCR. We will exclude studies focused on 'for-cause' biopsies. Both title, abstract screening and full-text screening will be performed by two or more reviewers. The primary outcome of this study will be death-censored allograft loss. The secondary outcome will include development of subsequent rejection. For tim</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jul</publication><modification>2025-04-04T14:46:07.457Z</modification><creation>2025-04-04T14:46:07.457Z</creation></dates><accession>S-EPMC11261677</accession><cross_references><pubmed>39025816</pubmed><doi>10.1136/bmjopen-2024-085098</doi></cross_references></HashMap>